Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.

JAMA Editor’s Summary

Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 14, 2015 issue

July 14, 2015

Listen on your favorite player Take me to this show’s page

Newer →

Avian flu vaccine adjuvants, bystander intervention for cardiac arrest, atrial fibrillation treatment, and more.

← Older

Diagnosis and treatment of venous thromboembolism, stroke and cognitive decline, mortality from combined CHD-stroke-diabetes, and more.

Facebook Twitter Buffer LinkedIn WhatsApp

Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.

Editor’s Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 14, 2015 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00